Both in Lab Analytical Instruments
Pacific Biosciences of California vs Alamar Biosciences
Over the past year PACB returned +100.4% and ALMR returned +9.7%; their daily moves had a correlation of 0.52.
PACB +100.4% ALMR +9.7%Growth of $1, one year, split-adjusted
| Metric | PACB | ALMR |
|---|---|---|
| Price | $2.61 | $30.60 |
| Market cap | $809.7M | $2.12B |
| Today | −10.17% | −10.11% |
| 1 month | +3.8% | −5.7% |
| 6 months | +62.8% | — |
| Year to date | +39.3% | — |
| 1 year | +29.6% | — |
| Revenue growth (YoY) | −1.9% | — |
| Gross margin | 32.4% | 60.2% |
| Net margin | −114.7% | −44.9% |
| P/E (TTM) | — | — |
| Price / sales | 5.1× | — |
| Net cash | -$407.5M | $240.1M |
| Dividend yield | — | — |
| Volatility (60d) | 114.2% | — |
| Short % of float | 18.2% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).